Kringle Pharma Inc (4884) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	18.11M	18.57M	17.43M	287.15M
Cost of goods sold	-	-	-	70.39M
Cost of revenue	-	-	-	70.39M
Research and development expenses	681.00M	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-492.41M	218.48M	333.52M	335.44M
Operating expense	188.59M	218.48M	333.52M	335.44M
Total operating expenses	188.59M	218.48M	333.52M	405.83M
Operating income	-170.48M	-199.91M	-316.09M	-118.67M
Other non operating income	-6.00M	38.00K	962.00K	1.40M
EBT including unusual items	-176.64M	-201.48M	-313.52M	-114.70M
EBT excluding unusual items	-176.64M	-200.05M	-313.95M	-114.70M
Income tax expense	-121.00K	372.00K	628.00K	372.00K
Effective tax rate	0.07%	-0.18%	-0.20%	-0.32%
Other operating expenses	-	-	-	-
Net income	-176.52M	-201.85M	-314.15M	-115.08M
Net profit margin	-974.87%	-1,086.97%	-1,802.35%	-40.07%
Earnings per share	-	-	-	-
Interest and investment income	-	-	1.00M	-
Interest expense	-141.00K	-	-	-
Net interest expenses	-141.00K	-	1.00M	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance